KinDex Pharmaceuticals Receives $5,000,000 Series A Financing Round

  • Feed Type
  • Date
    3/26/2014
  • Company Name
    KinDex Pharmaceuticals
  • Mailing Address
    800 Fifth Avenue Seattle, WA 98104 USA
  • Company Description
    KinDex was established in the fall of 2009 to focus on the discovery and development of molecules that modulate key regulatory networks associated with chronic disease.
  • Website
    http://www.kindexus.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Their investment will help us initiate the planned Phase 2 trial of our most advanced candidate, KDT501, in Type 2 diabetic patients as well as undertake additional preclinical and mechanistic studies in brown fat biology.
  • M&A Terms
  • Venture Investor